Future uncertain for Ottawa-based medical research organizations

A change in the way the federal government funds scientific research is jeopardizing the future of two high-profile Ottawa-based organizations aimed at bringing cutting-edge medical research to Canadian patients.
Ottawa’s Dr. John Bell, who is scientific director of BioCanRx, says the nation-wide immunotherapy network is being “cut off at the knees” by funding changes announced last week.
A senior scientist in cancer therapeutics at The Ottawa Hospital, Bell is considered a glo